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Background: Clinical guidelines for management of patients with chronic obstructive 
  pulmonary disease (COPD) include recommendations based on high levels of evidence, but 
gaps exist in their implementation. The aim of this study was to examine the perspectives of 
medical practitioners regarding implementation of six high-evidence recommendations for the 
management of people with COPD.
Methods: Semi-structured interviews were conducted with medical practitioners involved with 
care of COPD patients in hospital and general practice. Interviews sought medical practitioners’ 
experience regarding implementation of smoking cessation, influenza vaccination, pulmonary 
rehabilitation, guideline-based medications, long-term oxygen therapy for hypoxemia and plan 
and advice for future exacerbations. Interviews were audiotaped, transcribed verbatim and 
analyzed using content analysis.
Results: Nine hospital-based medical practitioners and seven general practitioners participated. 
Four major categories were identified which impacted on implementation of the target recom-
mendations in the care of patients with COPD: (1) role clarity of the medical practitioner; 
(2) persuasive communication with the patient; (3) complexity of behavioral change required; 
(4) awareness and support available at multiple levels. For some recommendations, strength 
in all four categories provided significant enablers supporting implementation. However, with 
regard to pulmonary rehabilitation and plans and advice for future exacerbations, all identified 
categories that presented barriers to implementation.
Conclusion: This study of medical practitioner perspectives has indicated areas where sig-
nificant barriers to the implementation of key evidence-based recommendations in COPD 
management persist. Developing strategies to target the identified categories provides an 
opportunity to achieve greater implementation of those high-evidence recommendations in the 
care of people with COPD.
Keywords: chronic obstructive pulmonary disease, guideline implementation, barriers, enablers, 
medical practitioners, qualitative research
Background
Chronic obstructive pulmonary disease (COPD) is a common chronic condition with 
a high personal and public health cost.1 International and national guidelines for the 
management of COPD patients have made care recommendations based on high levels 
of research evidence.2,3 Recommendations for smoking cessation, influenza vaccination, 
pulmonary rehabilitation, guideline-based medications, and long-term oxygen therapy 
for hypoxemia, are all supported by systematic reviews of randomized controlled trials2,3 International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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(or “Level 1”4 evidence). The use of an “action plan” to plan 
for and help patients to manage exacerbations is supported 
by “Level 2”4 research evidence (one or two high quality 
randomized controlled trials).2,3
Despite high levels of evidence, implementation of 
these six recommendations in COPD care is reported to be 
  low–moderate.5–9 While there is room for improvement in the 
implementation of all six of these key treatment recommen-
dations, pulmonary rehabilitation (PR) and the use of action 
plans appear the most underutilized. A systematic review of 
international surveys reported that between 3% and 16% of 
suitable patients with COPD may be referred for PR, and as 
few as 1%–2% may receive this intervention.10 In a prospec-
tive study of patients with COPD admitted to hospital for 
management of an exacerbation, action plans were reported 
in 24.4% of cases.11
In the substantial body of evidence around knowledge 
translation, determining barriers and enablers to evidence 
implementation is a necessary step in developing strategies to 
improve translation of evidence into practice.12,13   Barriers to 
the implementation of clinical guidelines in general amongst 
medical practitioners have been examined   previously. 
A meta-synthesis of qualitative research on general practi-
tioners’ (GPs) attitudes to clinical practice guidelines found a 
key theme was GP concern with applying research findings to 
individuals, where these were felt to conflict with individual 
patients’ needs.14 Another systematic meta-review identified 
four factors influencing the implementation of clinical guide-
lines in general amongst health professionals: characteristics 
of the guideline (eg, low resource requirement), characteris-
tics of professionals (eg, awareness and familiarity), patient 
characteristics (eg, comorbidities) and environmental char-
acteristics (eg, lack of peer or colleague support).15
Barriers to high evidence care recommendations have 
been examined specifically in relation to COPD management. 
Focus groups and a questionnaire were used to investigate 
barriers to the implementation of an evidence-based guideline 
for COPD patient care, identifying “social” barriers (eg, need 
for a greater sense of ownership over guidelines) and practical 
barriers such as workload and limited time.16
However, these studies have all examined barriers to 
guidelines as a whole. No information regarding medi-
cal practitioners’ perspectives on implementing different 
care recommendations of equally high evidence within the 
guidelines is available. Therefore, the aim of this study was 
to examine the perspectives of medical practitioners regard-
ing implementation of six high-evidence recommendations 
for the management of people with COPD. The experiences, 
perceived barriers to, and enablers of implementation could 
highlight issues associated with lower implementation of 
specific recommendations where these exist. Examining 
strategies and attitudes of medical practitioners regarding 
COPD care recommendations that are being well imple-
mented could inform development of interventions to better 
address those that are not.
This study sought to examine two questions: (1) What 
are medical practitioners’ experiences of implementing six 
key COPD guideline recommendations in their patients, and 
(2) What do medical practitioners experience as barriers to, and 
enablers of, implementation of these recommendations?
Methods
A descriptive qualitative study design was used to explore 
the implementation of COPD guideline recommendations 
amongst hospital-based medical practitioners and GPs. 
Ethical approval to conduct this study was obtained from the 
University of South Australia Human Research and Ethics 
Committee and the Royal Adelaide Hospital Human Ethics 
Committee prior to commencement.
Participants
This study formed part of an evaluation of all patients admit-
ted to a tertiary hospital with a primary diagnosis of COPD 
exacerbation during a 2 month period. For all recruited 
patients, telephone contact was made with their hospital-
based medical practitioner (general medicine medical 
registrars or interns) during admission, inviting them to join 
the study. One month after each patient had been discharged 
from hospital, contact was made with the patients’ GPs, 
inviting them to also participate in the study. In this way, 
a homogeneous purposive sample of medical practitioners 
actively involved in the care of COPD patients, from both 
tertiary and primary care settings, was obtained. Informed 
consent to participate in the study was gained from all medi-
cal practitioners involved.
Data collection
Short semi-structured interviews were conducted with medi-
cal practitioners regarding their perspectives on implemen-
tation of target COPD recommendations, and barriers and 
facilitators to this process. Interviews were conducted face-
to-face in a private setting and audiotaped. A single researcher 
(post-doctoral research fellow with qualitative research expe-
rience and clinical practice in COPD   management) conducted International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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all interviews. The interview guide asked questions about 
(1) medical practitioners’ experiences of implementing each 
guideline recommendation (ie,   smoking cessation, influenza 
vaccination, pulmonary rehabilitation, guideline-based medi-
cations, long-term oxygen therapy for hypoxemia, plan and 
advice for future exacerbations); (2) barriers to, and enablers 
of, implementation of each guideline recommendation 
  (further detail supplied in Appendix). These recommenda-
tions were selected as they were supported by high levels of 
evidence in local3 and international2 guidelines.
Data analysis
Audio recordings of interviews with participants were 
transcribed verbatim, and the transcripts were content analy-
sed17,18 to identify and classify categories within the data 
in relation to the research questions. Content analysis has 
been described as a method of “subjective interpretation of 
the content of text data through the systematic classification 
process of coding and identifying themes or patterns.”18 In 
this study, the systematic classification process specifically 
involved:
1.  Identifying excerpts which related to the research 
questions.
2.  Organization of groups of excerpts into categories.
3.  Comparing excerpts and categories with existing analy-
ses of barriers and enablers to evidence-based health 
care implementation. To avoid being restricted to any 
one behavior change theory, a consensus based model 
of theoretical domains for investigating evidence-based 
practice was used.19
4.  Re-reading transcripts for further relevant data, with 
ongoing adjustment and final sorting into major   categories 
(formed by groupings of minor categories).17
Study rigor was maintained by adherence to standardized 
data collection protocol including use of a semi-structured 
interview guide developed a priori, transcription by an inde-
pendent typist, and subsequent validation by the interviewer. 
An independent analyst experienced in qualitative research 
reviewed a random selection of 20% of the transcripts to 
identify themes from the data. Differences were contested 
through discussion and consensus reached.
Results
Nine hospital based medical practitioners (five registrars, 
four interns) were invited to participate in the study and all 
agreed. Fifteen GPs were contacted, of whom seven joined 
the study.
Analysis led to the identification of four major categories 
which impacted on implementation of the target recommen-
dations in the care of patients with COPD. Major categories 
identified across all COPD care   recommendations were 
(1) role clarity of the medical practitioner; (2) persuasive 
communication with the patient; (3) complexity of behav-
ioral change required of the patient and medical practitio-
ner; (4) awareness and support available at multiple levels 
(Table 1). In the case of smoking cessation, long-term oxygen 
use if hypoxemic, influenza vaccination and guideline-based 
medication use, strategies and beliefs that enabled imple-
mentation were predominant in the interview data. Barriers 
to implementation were predominant regarding PR and plan 
and advice for future exacerbations.
role clarity
Medical practitioners used confident language to describe 
their participation in implementation of guideline recom-
mendations where a high level of role clarity existed. 
  Smoking cessation and influenza vaccinations were dis-
cussed with patients “all the time”, “always”, “usually” or 
“definitely”. Smoking cessation advice was perceived by 
both groups of doctors to be most effective when imple-
mented by the GP rather than the hospital-based medical 
practitioner.
Prescription of guideline-based medication was clearly 
described as “standard issue” and part of the role for both 
hospital-based medical practitioners and GPs.   Responsibility 
for prescription of long-term oxygen use for hypoxemia was 
perceived as outside the roles of both general medicine regis-
trars and GPs, falling to the respiratory specialist. However, 
the delineation was clear, as was the perceived role of the 
interviewed medical practitioners in the process.
In contrast, our data indicated a low degree of clarity 
about the role of the medical practitioners in referring COPD 
patients to PR. Hospital-based medical practitioners were 
unclear on patient eligibility for rehabilitation, and some GPs 
had not considered PR in the management of their COPD 
patients as in this excerpt:
Not much awareness. I don’t know what it is to be honest. I’ve 
got some people who have had this, but it was always initiated 
from the hospital, never initiated from me. (GP03)
Persuasive communication
Almost all GPs were actively engaged in strong persuasive 
communication regarding smoking cessation with their 
COPD patients who were current smokers, even where International Journal of COPD 2011:6
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Strong enablers, few barriers 
Influenza
vaccination
Medication
home oxygen
Smoking
cessation
Pulmonary
rehabilitation
Exacerbation
management
Adopt
discrete
medical
procedure
Adopt daily
medications
on doctors
advice
Lifestyle
change
with
medication
assistance
Lifestyle
change
and
attendance
at sessions
Whole of life
disease
management
strategy
Simple behavior change Complex behavior change
Fewer enablers, complex multi-level barriers
Figure 1 relationship between complexity of behavior change and ease of implementation for COPD care recommendations.
Abbreviation: COPD, chronic obstructive pulmonary disease.
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medical practitioners expressed concern about their ability 
to effect change:
I really push it hard. With my computer it tells me if they 
smoke or don’t smoke. I always discuss with them “What 
about giving up?” But the thing is they’ve got to want to give 
it up. There’s no good me telling them it’s bad for them. If 
they don’t want to do it, it won’t happen. But I try to plant 
the seed, yes. (GP08)
If I need more persuasive arguments, I will say “Are 
you going to wait til you’ve had your first stroke?” and 
that sometimes rings a bell, and I will talk to them about 
switching on their brain to quit. (GP05)
Medical practitioners used a number of different 
approaches and arguments to tailor smoking cessation 
discussions to the perceived needs and motivations of their 
patients and in some cases took care not to condemn or blame 
the patient. The extent of efforts to communicate regarding 
this recommendation was underpinned by high clinician 
belief in the health benefits of smoking cessation for their 
patients. Similarly, medical practitioners described they 
frequently checked the vaccination status of COPD patients, 
and expressed a high level of belief in the health benefits of 
influenza vaccination for this group.
In contrast, medical practitioners reported a spectrum of 
experience and attitudes regarding giving patient advice on 
use of medication for self-management of   exacerbations. 
Decisions about whether or not to recommend an 
action plan took into consideration patients’ perceived 
decision-making ability and symptom recognition. While 
a few instances of persuasive communication with patients 
regarding participation in PR were identified, in most cases 
interview data reflected low awareness and support for PR, 
for example:
I think it is something that is not out there openly that we 
forget to be able to refer, so I think if it was more publicized 
and we had more awareness of these things being around 
we would probably refer more people. (HD3)
Complexity of behavior change
The ease of implementation of COPD care recommendations 
by medical practitioners was associated with the complex-
ity of behavior change required (Figure 1). For example, 
annual influenza vaccinations, or institution of long-term 
oxygen in hypoxemic patients were described as simple, 
well-established processes:
That one is quite well established. So we’ll ring up the 
  thoracic consultant to approve it and we’ll ring up the 
  oxygen nurse. So that line is very established. (HD1)
However, care recommendations which required a high 
degree of behavior change, such as attendance at PR, were 
recognized as more difficult for patients to adopt. While 
some medical practitioners appreciated the health benefits 
achievable through PR, many were aware of the time, travel 
and effort required for patients to attend a PR program, and 
in many instances the costs were judged to outweigh the 
perceived benefits.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Well they’ve got to be motivated. And they’ve got to have 
the intellectual ability and the organizational skills to get 
there. And the time available to attend … They have to be 
physically able to get there. They have to be able to have 
transport. (GP11)
Similarly, provision of a plan and advice for   management 
of future exacerbations required complex self-management 
behaviors from the patients, including cognitive skills, 
symptom recognition, decision making, anxiety   regulation, 
and changes to lifestyle. Here medical practitioners 
appeared concerned that patients did not often have these 
health literacy and translational skills or self-confidence to 
enact agreed self-treatment actions, but medical practitio-
ners lacked means or time to teach the skills required for 
self-management.
Awareness and support
Well-implemented COPD care recommendations were 
facilitated by high levels of community, organizational, clini-
cian and patient support. For example, medical practitioners 
described implementation of influenza vaccinations as sup-
ported by a visible public health campaign and high com-
munity awareness. Within their organizations implementation 
was facilitated by computerized decision support systems 
and nurse-run clinics to administer the vaccine. Similarly, 
guideline-based medication in COPD patients was supported 
organizationally by continuing education and seminars, and 
implementation by ward-based pharmacists and general prac-
tice nurses. Implementation of smoking cessation in COPD 
patients, already supported by public health campaigns and 
legislative change, had moderate support available through 
a telephone counselling service.
However, low levels of clinician awareness of PR 
reflected less support at all levels for implementation 
of this therapy in COPD patients. Structurally, medical 
practitioners mentioned the difficult or unclear refer-
ral process, and long waiting periods, which presented 
barriers to implementation. Medical practitioners raised 
broader issues of ongoing chronic disease management in 
patients with COPD in relation to the use of action plans. 
The lack of service after hospital discharge for patients 
with COPD who are anxious and require reassurance and 
advice regarding exacerbation was indicated by one hos-
pital doctor. A number of GPs described COPD patients 
who frequently called the GP for reassurance and advice 
regarding symptom interpretation and the need to com-
mence additional medication.
Discussion
This study explored the views of medical practitioners in 
hospital and general practice related to implementation of six 
high-evidence care recommendations for patients with COPD. 
The analysis of medical practitioner interviews identified four 
main issues that impacted on implementation: clarity of the 
doctor’s role; use of persuasive communication; nature of the 
behavior change required; and awareness and support strate-
gies available at multiple levels. We have highlighted how 
for some well implemented COPD care recommendations, 
all four areas were strong; but for other   recommendations, a 
number of these areas were less well developed.
Barriers and enablers to guideline implementation in 
COPD16,20 and other conditions14,15,21,22 have been previ-
ously studied, looking at the guideline as a whole. However 
previous studies have not examined the reasons why some 
high-evidence recommendations within a guideline are well 
implemented and others are not. Low implementation of 
evidence-based care recommendations in people with COPD 
translates into poorer outcomes for patients, and greater cost 
to the health care system.23 Of particular concern are recom-
mendations that have high evidence for their efficacy but low 
implementation levels; in the case of our study, referral to PR. 
Our data indicated this care recommendation was not clearly 
adopted as part of medical practitioners’ role in the care of 
people with COPD either in primary or tertiary settings. It 
was associated with a high level of required behavior change, 
and community, organizational or clinical factors were seen 
to be unsupportive.
Identifying the overarching themes which supported 
implementation of high-evidence COPD care recommenda-
tions in this sample provides an opportunity for translating 
the effective strategies that enable highly implemented 
recommendations to be adopted and modifying these for 
recommendations with low implementation. For example, 
improving implementation for PR or action plans could 
involve strategies which have been successful for other 
interventions, such as the use of computerized decision sup-
port, and attention to structural and organizational change 
(eg, greater involvement of GP practice nurses).
Categories identified in this study have resonance with 
established frameworks describing barriers and enablers to 
implementation. Compatibility of guideline implementation 
with the clinician’s professional role has previously been 
described as a key factor,19 and is also highly specific to the 
sample. For example, in this study the prescription of oxygen 
for hypoxemic patients was seen as a “  well-established” International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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process from the perspective of the GP and general   medicine 
registrar, which masks the documented problems with 
criteria-based oxygen prescription including variability in 
service provision24 and inappropriate prescription.25 The use 
of persuasive communication by medical practitioners in this 
study included sub-categories of awareness and familiarity 
with recommendations, belief in health benefits, motivation 
and prioritization, all frequently described as influential 
in whether or not clinicians implement evidence-based 
practice.14,19,21 These sub-categories were all low with regard 
to PR. Lack of persuasive health professional communica-
tion appears to be a central issue associated with low referral 
to PR in COPD,26 and has been identified in a systematic 
review of patient reasons for non-attendance as a major 
  barrier.27   Further strategies to enhance medical practitioners’ 
  awareness and familiarity with PR, belief in both the health 
benefits and cost-effectiveness of PR, motivation to consider 
referral of appropriate patients, and prioritization of the 
implementation of PR in COPD by health administrations 
warrant specific development and careful evaluation.
While the complex nature of change required for imple-
mentation of PR, or planning for management of future exac-
erbations, in itself may not be modifiable, recognition and 
greater support for the degree of behavior change required 
must be acknowledged and extra targeted support made avail-
able if these guidelines are to be successfully implemented. 
This may include greater assistance with patient access, 
greater flexibility in service delivery, assisting patients to 
gain skills in self-management, and opportunities for case-
management where COPD is complicated by comorbidities 
(particularly mental illness or cognitive decline) or social 
  disadvantage. While some care recommendations are sup-
ported by layers of public awareness, legislative and financial 
support, and organizational processes (eg, influenza vaccina-
tion), others of high-evidence (eg, PR, plan and advice for 
future exacerbations) lack funding, organizational or proce-
dural support and have low community awareness.
By purposively recruiting specific medical practitioners 
from both hospital and general practice settings, our sample 
reflected clinicians from both tertiary and primary care who 
were involved in current management of people with COPD. 
Further research could investigate the perspectives of other 
clinicians closely involved with care of people with COPD 
including respiratory physicians, general practice nurses and 
allied health professionals. More studies seeking to deter-
mine incidence of the implementation of PR or action plans 
as a percentage of suitable COPD patients attending either 
primary or tertiary health services, would help   document the 
extent of the evidence-practice gaps in these areas. The find-
ings of this qualitative study explored perceptions of a defined 
number of hospital-based and general medical practitioners 
in one local area, and there is no intention to generalize the 
findings to other settings. However, given the international 
issues regarding implementation of COPD guidelines, per-
spectives of medical practitioners identified in this study may 
prompt further investigation, especially where interventions 
are being designed to improve care.
In conclusion, this study of doctor perspectives on the 
implementation of high-evidence treatment recommen-
dations in COPD has indicated areas where role clarity, 
persuasive communication, and multi-level support for the 
recommendations are strong, and the nature of behavior 
change required is not complex. However in other aspects 
of high-evidence care, enablers in many or most of these 
areas are lacking. Greater implementation is unlikely to be 
achieved unless these issues are addressed in systematic, 
targeted ways. Data and analysis from this study point the 
way to development of interventions which address the identi-
fied factors, moving toward the desired result of improving 
implementation of high-evidence recommendations in the 
care of people with COPD.
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Appendix
Overview of semi-structured interview 
guide: medical practitioners
Information was sought regarding (1) medical practitioners’ 
experiences of implementing each guideline recommendation 
(ie, smoking cessation, influenza vaccination, pulmonary 
rehabilitation, guideline-based medications, long-term 
oxygen therapy for hypoxemia, plan and advice for future 
exacerbations); (2) barriers to, and enablers of, implementa-
tion of each guideline recommendation.
Starter questions as below were used to seek this 
  information. Follow-up questions depended on individual 
participant responses, and prompts were used to gather 
more detailed information about barriers and facilitators to 
the implementation of recommendations in relation to each 
intervention strategy.
smoking cessation
For COPD patients who are current smokers, would you in 
general initiate smoking cessation therapy if this hasn’t been 
done? What would this involve?
What are the barriers to you using these sorts of 
strategies?
Are there things that facilitate you implementing smoking 
cessation therapy?
Pulmonary rehabilitation
Pulmonary rehabilitation (PR) may benefit a subgroup of 
patients with COPD.
Have you been involved with recommending pulmonary 
rehabilitation for any patients with COPD?
In general what would indicate you to refer a patient 
for PR?
What do you see as the barriers with getting suitable 
COPD patients you see into pulmonary rehab?
What strategies or structures are in place to help you get 
suitable COPD patients to PR?
Influenza vaccination
Hospital-based medical practitioners: Would you generally 
check with COPD inpatients about whether they have had 
an influenza vaccination? Would you take any action if they 
hadn’t had one?
General practitioners: Are you involved with providing 
influenza vaccinations to COPD patients?
Both: What factors help the implementation of influenza 
vaccinations in COPD patients?
Oxygen use if hypoxemic
If a patient needs home oxygen, how does this treatment 
get implemented? What strategies are in place to facilitate 
assessment and implementation of oxygen for chronically 
hypoxemic patients? Are there barriers to this process?
Medication use
Clearly medication is an important part of management for 
patients with COPD; what do you generally prescribe? Are 
there things that influence you in making decisions about 
prescription for COPD patients?
Are there ways you find useful to help patients get access 
to and effectively take the prescribed medication (prompts: 
use of devices, checking of adherence and device use)?
Are there factors that make it difficult for patients to get 
access to and effectively take the required medication?
Plan and advice for management  
of COPD exacerbations
Do you discuss with COPD patients how to recognize and 
what to do in the event of a future exacerbation? What advice 
do you give? Do you write this down or make use of other 
resources to communicate this to the patient? Why does/
doesn’t this get implemented?